A previous study of the mechanisms of the antiproliferative activity of butein has shown that the proliferation and invasion of bladder cancer cells was inhibited by butein through the activation of ERK1/2 and NF-κB signaling pathways [23]. Here, MAPK3 is linked to urinary bladder cancer.